US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco S&P 500 Equal Weight Health Care ETF

36.58

+0.50001.39%

Pre-market: 36.580.00000.00%08:17 EDT

Volume:170.67K

Turnover:6.23M

Market Cap:844.63M

PE:- -

High:36.63

Open:36.48

Low:36.29

Close:36.08

52wk High:38.19

52wk Low:28.26

Shares:23.09M

Float Shares:23.09M

Volume Ratio:1.87

T/O Rate:0.74%

Dividend:0.23

Dividend Rate:0.63%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Alterity Therapeutics to Spotlight MSA Program at Cantor Global Healthcare Conference

Citizens biotechnology analyst holds analyst/industry conference call

Shenzhen Regulator Launches 2026 Roadshow Selection for Key Medical Device Innovation Projects

Shinva Medical Secures Class II and III Device Approvals for Advanced Radiotherapy and Thoracoscopic Systems

Ajinomoto Advances Major Share Buyback, Plans Cancellation of Repurchased Stock

Aptabio Therapeutics Plans Seoul NDR to Deepen R&D Dialogue with Institutions

港股动态：今海医疗科技股价攀升逾4%，中期收益激增逾1.3倍，核心业务向高附加值医疗器械领域转型

Tellgen Corporation Secures Six New Medical Device Approvals

Medical Sector Hitting an Earnings Inflection Point? 512170 Ends Green Amid AI4S Boost for HK CXO Stocks

Latigo Biotherapeutics initiated with a Buy at Goldman Sachs

Shandong Oriental Ocean Secures Regulatory Approval for Its Scavenger Receptor-A Assay Kit

Actinogen Plans Major Share Placement to Bolster Funding Capacity

Incyte Reaches CMS Pact on Jakafi Medicaid Pricing

Teva to lower cost of select medicines for American patients covered by Medicaid

Here's How to Invest Using a Winning Strategy That Offers a Spin on Traditional Stock Index Funds

Eli Lilly Expands Beyond Weight-Loss Dominance With Potential $2.88B Autoimmune Deal

Guangdong Hybribio Biotech's Subsidiary Secures In Vitro Diagnostic Device Registration Certificate

Chimeric Therapeutics posts deeper loss as IP impairments push it into net liabilities

Protagonist announces Takeda received U.S. FDA approval for MIMRYLO

Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrzen.com/stock/RSPH/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RSPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RSPH\",,,,,undefined,":{"symbol":"RSPH","market":"US","secType":"STK","nameCN":"Invesco S&P 500 Equal Weight Health Care ETF","latestPrice":36.58,"timestamp":1789416000000,"preClose":36.08,"halted":0,"volume":170667,"hourTrading":{"tag":"盘前","latestPrice":36.58,"preClose":36.58,"latestTime":"08:17 EDT","volume":1,"amount":36.58,"timestamp":1789474627934,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.01385809312638581,"floatShares":23090000,"shares":23090000,"eps":0,"marketStatus":"Pre-Mkt","change":0.5,"latestTime":"09-15 08:24:14 EDT","open":36.48,"high":36.6348,"low":36.29,"amount":6229495.174959,"amplitude":0.009557,"askPrice":37.2,"askSize":30,"bidPrice":33.38,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789479000000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":36.58,"sharesOutstanding":23410000,"nav":36.10343,"aum":835072335.9,"dividendRate":0.006312,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":36.58,"preClose":36.58,"latestTime":"08:17 EDT","volume":1,"amount":36.58,"timestamp":1789474627934,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":36.58,"preClose":36.58,"latestTime":"19:30 EDT","volume":33,"amount":1211.8603,"timestamp":1789428601088,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.8704913783283967,"impliedVol":0.0046,"impliedVolPercentile":0.008},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RSPH\",,,,,undefined,":{"symbol":"RSPH","floatShares":23090000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.8704913783283967,"shares":23090000,"dividePrice":0.2309,"high":36.6348,"amplitude":0.009557,"preClose":36.08,"low":36.29,"week52Low":28.26,"pbRate":"--","week52High":38.19,"institutionHeld":0,"latestPrice":36.58,"committee":0.538462,"eps":0,"divideRate":0.006312,"volume":170667,"delay":0,"ttmEps":0,"open":36.48,"prevYearClose":31.85,"prevWeekClose":36.08,"prevMonthClose":37.4,"prevQuarterClose":33.19,"fiveDayClose":37.45,"twentyDayClose":36,"sixtyDayClose":31.43},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RSPH\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"RSPH","amount":0.06267,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"RSPH","amount":0.05609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"RSPH","amount":0.05305,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"RSPH","amount":0.05991,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"RSPH","amount":0.05546,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RSPH\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-30","value":0.198297,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.174967,"currency":"USD"},{"executeDate":"2023-06-20","recordDate":"2023-06-21","paymentDate":"2023-06-23","value":0.51083,"currency":"USD"},{"executeDate":"2023-09-18","recordDate":"2023-09-19","paymentDate":"2023-09-22","value":0.04794,"currency":"USD"},{"executeDate":"2023-12-18","recordDate":"2023-12-19","paymentDate":"2023-12-22","value":0.04988,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RSPH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RSPH\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664214842","title":"Alterity Therapeutics to Spotlight MSA Program at Cantor Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664214842","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664214842?lang=en_us&edition=fundamental","pubTime":"2026-09-03 07:47","pubTimestamp":1788392845,"startTime":"0","endTime":"0","summary":"Alterity Therapeutics ( ($AU:ATH) ) has provided an update. Alterity Therapeutics, a clinical-stage biotechnology company developing disease-modify...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alterity-therapeutics-to-spotlight-msa-program-at-cantor-global-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alterity-therapeutics-to-spotlight-msa-program-at-cantor-global-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","BK4007","IBB","SYNB","XLV","LU0029874061.USD","RSPH","XBI","DARP","BBP","LU0128526141.USD","BBC","BK4581","JDOC","BK4539","IEIH","LNGR","BK4588","HCSG","LABU","AGNG","BK4585","FWD","BK4137","FHLC","XT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664843934","title":"Citizens biotechnology analyst holds analyst/industry conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2664843934","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664843934?lang=en_us&edition=fundamental","pubTime":"2026-09-03 00:45","pubTimestamp":1788367511,"startTime":"0","endTime":"0","summary":"Analysts discuss showcasing Twilio’s (TWLO) SIGNAL highlights on an Analyst/Industry conference call to be held on September 4. Published first on ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/citizens-biotechnology-analyst-holds-analyst-industry-conference-call-thefly-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/citizens-biotechnology-analyst-holds-analyst-industry-conference-call-thefly-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4608","LU1668664300.SGD","LU1791807156.HKD","LU2357305700.SGD","CLOU","LNGR","JDOC","BBP","BK4548","BK4551","LU0012050646.USD","LU1861559042.SGD","TWLO","LU0205194284.USD","LU0661504455.SGD","LU1720051108.HKD","FHLC","XT","BK4613","BK4585","FWD","LU0738911758.USD","SYNB","LU1548497426.USD","LU1861558580.USD","LU1720051017.SGD","LU2237438978.USD","BK4211","LU0345770993.USD","BK4588","BK4528","IEIH","AGNG","DARP","IAT","IBB","CFG","LU0106831901.USD","LU0106261612.USD","LU0345770308.USD","BK4116","LU0949170772.SGD","LU0205193047.USD","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149967319","title":"Shenzhen Regulator Launches 2026 Roadshow Selection for Key Medical Device Innovation Projects","url":"https://stock-news.laohu8.com/highlight/detail?id=1149967319","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149967319?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:44","pubTimestamp":1788349448,"startTime":"0","endTime":"0","summary":"To advance high-quality development in the medical device industry and uncover promising local innovations, the Shenzhen Municipal Market Supervision Administration recently organized a roadshow and...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGNG","RSPH","GDOC","BK1583","BK1574","MDEV","09996","IEIH","MEDX","BK1100","PTH","HART","159883","LGHT","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186287506","title":"Shinva Medical Secures Class II and III Device Approvals for Advanced Radiotherapy and Thoracoscopic Systems","url":"https://stock-news.laohu8.com/highlight/detail?id=1186287506","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186287506?lang=en_us&edition=fundamental","pubTime":"2026-09-02 15:51","pubTimestamp":1788335497,"startTime":"0","endTime":"0","summary":"Shinva Medical Instrument Co.,Ltd. (600587.SH) has announced that it recently received the Medical Device Registration Certificate from China's National Medical Products Administration, while its...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","09996","BK1583","159883","BK1574","RSPH","LNGR","BK0028","LGHT","BK1100","AGNG","GDOC","BK0188","HART","600587","MDEV","BK0251","MEDX","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664891664","title":"Ajinomoto Advances Major Share Buyback, Plans Cancellation of Repurchased Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2664891664","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664891664?lang=en_us&edition=fundamental","pubTime":"2026-09-02 14:53","pubTimestamp":1788331999,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Ajinomoto Co ( ($JP:2802) ). Ajinomoto Co., Inc., a leading Japanese food and biotechnology group listed on the...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ajinomoto-advances-major-share-buyback-plans-cancellation-of-repurchased-stock?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ajinomoto-advances-major-share-buyback-plans-cancellation-of-repurchased-stock?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGNG","FHLC","BK4588","DARP","BBP","JDOC","LNGR","RSPH","SYNB","XT","BK4585","IEIH","IBB","FWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664997828","title":"Aptabio Therapeutics Plans Seoul NDR to Deepen R&D Dialogue with Institutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2664997828","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664997828?lang=en_us&edition=fundamental","pubTime":"2026-09-02 14:21","pubTimestamp":1788330080,"startTime":"0","endTime":"0","summary":"Aptabio Therapeutics, Inc. ( ($KR:293780) ) has provided an update. Aptabio Therapeutics, Inc., a biotechnology company focused on research and dev...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aptabio-therapeutics-plans-seoul-ndr-to-deepen-rd-dialogue-with-institutions?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aptabio-therapeutics-plans-seoul-ndr-to-deepen-rd-dialogue-with-institutions?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4588","BK4007","IBB","IEIH","BK4585","BK4539","DARP","FWD","BBP","JDOC","LENZ","AGNG","LNGR","SYNB","FHLC","RSPH","XT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184201272","title":"港股动态：今海医疗科技股价攀升逾4%，中期收益激增逾1.3倍，核心业务向高附加值医疗器械领域转型","url":"https://stock-news.laohu8.com/highlight/detail?id=1184201272","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184201272?lang=en_us&edition=fundamental","pubTime":"2026-09-02 14:10","pubTimestamp":1788329416,"startTime":"0","endTime":"0","summary":"今海医疗科技（02225）股价今日表现活跃，盘中涨幅一度超过5%。截至最新交易时段，该股上涨4.08%，报4.72港元，成交额达628.74万港元。据近期披露的2026年中期业绩显示，公司在营收扩张与盈利质量方面均呈现积极态势。报告期内，集团实现收益3402.1万新加坡元，较去年同期大幅增长134.16%，彰显出强劲的销售增长动能。从业务结构来看，2026年上半年，公司收入构成实现显著优化，战略重...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KCAI","09996","BK4588","GDOC","PTH","LNGR","159883","02225","BK1583","RSPH","VXUS","MEDX","MDEV","AGNG","BK1100","BK1150","BK4585","BK1574","IEIH","LGHT","HART"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157462487","title":"Tellgen Corporation Secures Six New Medical Device Approvals","url":"https://stock-news.laohu8.com/highlight/detail?id=1157462487","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157462487?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:36","pubTimestamp":1788262589,"startTime":"0","endTime":"0","summary":"Tellgen Corporation (300642.SZ) has announced that the company and its controlling subsidiary, Shanghai Maishi Biotechnology Co., Ltd., recently obtained six medical device registration certificates...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","BK0046","AGNG","HART","GDOC","300642","BK1574","09996","BK0042","BK1583","LGHT","BK0239","LNGR","PTH","BK1100","159883","IEIH","MDEV","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141380242","title":"Medical Sector Hitting an Earnings Inflection Point? 512170 Ends Green Amid AI4S Boost for HK CXO Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=1141380242","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141380242?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:20","pubTimestamp":1788261656,"startTime":"0","endTime":"0","summary":"On September 1st, medical stocks in both A-shares and Hong Kong markets bucked the market's downbeat trend, with related products such as Medical ETF Huabao (512170) and HK Stock Connect Medical ETF...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RSPH","BK1583","FLHK","MDEV","09996","IEIH","MEDX","BK1100","WX","512170","CXO","PTH","KCAI","BK4588","HART","159883","BK4585","AGNG","GDOC","BK1574","VXUS","LGHT","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883471","title":"Latigo Biotherapeutics initiated with a Buy at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883471","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883471?lang=en_us&edition=fundamental","pubTime":"2026-09-01 16:30","pubTimestamp":1788251407,"startTime":"0","endTime":"0","summary":"Goldman Sachs initiated coverage of Latigo Biotherapeutics (LTGO) with a Buy rating and $73 price target Latigo is clinical-stage biotechnology com...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/latigo-biotherapeutics-initiated-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/latigo-biotherapeutics-initiated-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FHLC","LU0942090050.USD","LU2471134796.USD","LU2237443549.SGD","LU0251131958.USD","LU0106831901.USD","LU1868836914.USD","BK4504","LU0345770993.USD","LU1868837136.USD","SYNB","GSX","BK4127","FWD","LU1894683348.USD","IE0004086264.USD","LU1668664300.SGD","IE00B19Z3B42.SGD","BK4516","LU2896262040.SGD","LU2237438978.USD","LTGO","LU2237443895.HKD","LU2471134523.USD","LU2237443382.USD","IBB","BK4552","RSPH","BK4550","BBP","JDOC","IE0004091025.USD","IE0002270589.USD","IE00BSNM7G36.USD","LU1868836757.USD","LU2237443622.USD","AGNG","IE00BFXG1179.USD","LU1144417596.USD","DARP","BK4007","BBC","LNGR","BK4585","XT","LU0868494617.USD","LU0210536198.USD","LU1868836591.USD","LU0096364046.USD","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100056289","title":"Shandong Oriental Ocean Secures Regulatory Approval for Its Scavenger Receptor-A Assay Kit","url":"https://stock-news.laohu8.com/highlight/detail?id=1100056289","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100056289?lang=en_us&edition=fundamental","pubTime":"2026-09-01 16:06","pubTimestamp":1788249995,"startTime":"0","endTime":"0","summary":"Shandong Oriental Ocean Sci-Tech Co.,Ltd. (002086.SZ) announced that its wholly-owned subsidiary, Aviwe Bio-Tech Co., Ltd., has obtained the medical device registration certificate for the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0092","GDOC","BK0213","BK1583","IEIH","BK1574","MEDX","RSPH","PTH","HART","002086","LNGR","BK0046","159883","AGNG","LGHT","MDEV","09996","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664881767","title":"Actinogen Plans Major Share Placement to Bolster Funding Capacity","url":"https://stock-news.laohu8.com/highlight/detail?id=2664881767","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664881767?lang=en_us&edition=fundamental","pubTime":"2026-09-01 08:46","pubTimestamp":1788223606,"startTime":"0","endTime":"0","summary":"Actinogen Medical ( ($AU:ACW) ) just unveiled an update. Actinogen Medical Limited, an ASX-listed biotechnology company trading under the code ACW,...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/actinogen-plans-major-share-placement-to-bolster-funding-capacity?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/actinogen-plans-major-share-placement-to-bolster-funding-capacity?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FHLC","FWD","IEIH","SYNB","RSPH","JDOC","BK4588","BK4585","LNGR","IBB","BBP","DARP","AGNG","XT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883783","title":"Incyte Reaches CMS Pact on Jakafi Medicaid Pricing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883783","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883783?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:47","pubTimestamp":1788209252,"startTime":"0","endTime":"0","summary":"An announcement from Incyte ( ($INCY) ) is now available. Incyte Corporation said it has entered into an agreement with the U.S. Centers for Medica...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/incyte-reaches-cms-pact-on-jakafi-medicaid-pricing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/incyte-reaches-cms-pact-on-jakafi-medicaid-pricing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","BK4532","BK4585","BK4550","IDNA","BK4139","INCY","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664838898","title":"Teva to lower cost of select medicines for American patients covered by Medicaid","url":"https://stock-news.laohu8.com/highlight/detail?id=2664838898","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664838898?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:15","pubTimestamp":1788207308,"startTime":"0","endTime":"0","summary":"Teva (TEVA) Pharmaceuticals, a U.S. affiliate of Teva, announced a shared commitment with the Trump Administration to lower the cost of select medi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teva-to-lower-cost-of-select-medicines-for-american-patients-covered-by-medicaid-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teva-to-lower-cost-of-select-medicines-for-american-patients-covered-by-medicaid-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","BK4557","AFG","BK4588","LU1983299246.USD","TEVA","BK4559","BK4007","BK4596","BK4117","BK4107","LU2324357040.USD","BK4566","BK4585","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664700068","title":"Here's How to Invest Using a Winning Strategy That Offers a Spin on Traditional Stock Index Funds","url":"https://stock-news.laohu8.com/highlight/detail?id=2664700068","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664700068?lang=en_us&edition=fundamental","pubTime":"2026-09-01 02:30","pubTimestamp":1788201000,"startTime":"0","endTime":"0","summary":"Invesco S&P 500 Equal Weigh","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HELO","CPST","RSPF","RSPU","FEBT","XLU","XLC","BKLC","VYM","RSPH","XLF","SPY","GSUS","ACLC","FELC","NVDA","XLK","XLY","FLAO","XLP","RSPR","RSPS","MSFT","GBXB","CFO","FLCC","LGH","FDN","XLI","AAPL","GPIX","RSPG","SPYM","VUG","VOOG","XLV",".SPX","XLB","RSPT","VOO","RSPC","STT","RSPN","CGUS","RSPD","RSPM","XLE","ISSXF","XLRE","SCHG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131442769","title":"Eli Lilly Expands Beyond Weight-Loss Dominance With Potential $2.88B Autoimmune Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1131442769","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131442769?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:22","pubTimestamp":1788182577,"startTime":"0","endTime":"0","summary":"Eli Lilly and Co (NYSE: LLY) is set to acquire Merida Biosciences Inc. for up to $2.88 billion in cash, marking a strategic push into autoimmune and allergic disease treatments as the pharma giant...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FHLC","TRUH","NVOH","NVOX","PJP","XLVI","IYH","NBDS","CURE","MEDI","FXH","RSPH","THNR","PINK","NVOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115184678","title":"Guangdong Hybribio Biotech's Subsidiary Secures In Vitro Diagnostic Device Registration Certificate","url":"https://stock-news.laohu8.com/highlight/detail?id=1115184678","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115184678?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:40","pubTimestamp":1788165635,"startTime":"0","endTime":"0","summary":"Guangdong Hybribio Biotech Co., Ltd. (300639.SZ) announced that its wholly-owned subsidiary, Chaozhou Kaipu Bio-Chemistry Co., Ltd. (referred to as \"Kaipu Chemistry\"), has recently obtained the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0132","RSPH","159883","HART","PTH","BK0239","BK1100","300639","LNGR","GDOC","BK1583","BK0046","MEDX","MDEV","LGHT","AGNG","BK0042","IEIH","09996","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663753250","title":"Chimeric Therapeutics posts deeper loss as IP impairments push it into net liabilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2663753250","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663753250?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:33","pubTimestamp":1788165205,"startTime":"0","endTime":"0","summary":"Chimeric Therapeutics Ltd. ( ($AU:CHM) ) has shared an announcement. Chimeric Therapeutics Limited is a biotechnology company focused on cell-based...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/chimeric-therapeutics-posts-deeper-loss-as-ip-impairments-push-it-into-net-liabilities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/chimeric-therapeutics-posts-deeper-loss-as-ip-impairments-push-it-into-net-liabilities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","IBB","LNGR","BK4588","AGNG","XT","BK4007","LENZ","BBP","SYNB","IEIH","BK4139","BK4539","FWD","FHLC","BK4585","JDOC","DARP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663588047","title":"Protagonist announces Takeda received U.S. FDA approval for MIMRYLO","url":"https://stock-news.laohu8.com/highlight/detail?id=2663588047","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663588047?lang=en_us&edition=fundamental","pubTime":"2026-08-31 04:35","pubTimestamp":1788122107,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics (PTGX) announced that Takeda (TAK) received U.S. Food and Drug Administration, FDA, approval for MIMRYLO, a subcutaneously...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/protagonist-announces-takeda-received-u-s-fda-approval-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/protagonist-announces-takeda-received-u-s-fda-approval-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNMX","IYH","GDOC","BK4007","MRNY","LFSC","BMED","MRNX","TAK","BK4139","SYNB","RSPH","BBP","TBXU","IDNA","BK4585","NVIB","BK4588","FRTY","XLVX","LABU","PSCH","TECB","PINK","IBB","IEIH","MEDI","PTGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663019703","title":"Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO","url":"https://stock-news.laohu8.com/highlight/detail?id=2663019703","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663019703?lang=en_us&edition=fundamental","pubTime":"2026-08-29 08:52","pubTimestamp":1787964735,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Co ( ($JP:4502) ) just unveiled an announcement. Takeda has secured U.S. FDA approval for MIMRYLO (rusfertide), a first-in-cl...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-wins-fda-nod-for-first-in-class-polycythemia-vera-therapy-mimrylo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-wins-fda-nod-for-first-in-class-polycythemia-vera-therapy-mimrylo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBXU","NVIB","PSCH","MRNX","BBP","TECB","BMED","BK4588","GNMX","LABU","IBB","SYNB","MRNY","RSPH","XLVX","IDNA","BK4585","FRTY","PINK","GDOC","MEDI","IYH","IEIH","LFSC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}